Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Samarium × Clear all

NCT00126230 2006-09-11

Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms